Investigation of intrafractional spinal cord and spinal canal movement during stereotactic MR-guided online adaptive radiotherapy for kidney cancer.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 01 07 2024
accepted: 29 09 2024
medline: 31 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

This study aimed to investigate the intrafractional movement of the spinal cord and spinal canal during MR-guided online adaptive radiotherapy (MRgART) for kidney cancer. All patients who received stereotactic MRgART for kidney cancer between February 2022 and February 2024 were included in this study. Patients received 30-42 Gy in 3-fraction MRgART for kidney cancer using the Elekta Unity, which is equipped with a linear accelerator and a 1.5 Tesla MRI. MRI scans were performed at three points during each fraction: for online planning, position verification, and posttreatment assessment. The spinal cord was contoured from the upper edge of Th12 to the medullary cone, and the spinal canal was contoured from Th12 to L3, using the first MRI. These contours were adjusted to the second and third MR images via deformable image registration, and movements were measured. Margins were determined via the formula "1.3×Σ+0.5×σ" and 95% prediction intervals. A total of 22 patients (66 fractions) were analyzed. The median interval between the first and third MRI scans were 38 minutes. The mean ± standard deviation of the spinal cord movements after this interval were -0.01 ± 0.06 for the x-axis (right-left), 0.01 ± 0.14 for the y-axis (caudal-cranial), 0.07 ± 0.05 for the z-axis (posterior-anterior), and 0.15 ± 0.08 for the 3D distance, respectively. The correlation coefficients of the 3D distance between the spinal cord and the spinal canal was high (0.92). The calculated planning organ at risk volume margin for all directions was 0.11 cm for spinal cord. The 95% prediction intervals for the x-axis, y-axis, and z-axis were -0.11-0.09 cm, -0.23-0.25 cm and -0.14-0.03 cm, respectively. Margins are necessary in MRgART to compensate for intrafractional movement and ensure safe treatment delivery.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
This study aimed to investigate the intrafractional movement of the spinal cord and spinal canal during MR-guided online adaptive radiotherapy (MRgART) for kidney cancer.
MATERIALS AND METHODS METHODS
All patients who received stereotactic MRgART for kidney cancer between February 2022 and February 2024 were included in this study. Patients received 30-42 Gy in 3-fraction MRgART for kidney cancer using the Elekta Unity, which is equipped with a linear accelerator and a 1.5 Tesla MRI. MRI scans were performed at three points during each fraction: for online planning, position verification, and posttreatment assessment. The spinal cord was contoured from the upper edge of Th12 to the medullary cone, and the spinal canal was contoured from Th12 to L3, using the first MRI. These contours were adjusted to the second and third MR images via deformable image registration, and movements were measured. Margins were determined via the formula "1.3×Σ+0.5×σ" and 95% prediction intervals.
RESULTS RESULTS
A total of 22 patients (66 fractions) were analyzed. The median interval between the first and third MRI scans were 38 minutes. The mean ± standard deviation of the spinal cord movements after this interval were -0.01 ± 0.06 for the x-axis (right-left), 0.01 ± 0.14 for the y-axis (caudal-cranial), 0.07 ± 0.05 for the z-axis (posterior-anterior), and 0.15 ± 0.08 for the 3D distance, respectively. The correlation coefficients of the 3D distance between the spinal cord and the spinal canal was high (0.92). The calculated planning organ at risk volume margin for all directions was 0.11 cm for spinal cord. The 95% prediction intervals for the x-axis, y-axis, and z-axis were -0.11-0.09 cm, -0.23-0.25 cm and -0.14-0.03 cm, respectively.
CONCLUSIONS CONCLUSIONS
Margins are necessary in MRgART to compensate for intrafractional movement and ensure safe treatment delivery.

Identifiants

pubmed: 39475854
doi: 10.1371/journal.pone.0312032
pii: PONE-D-24-26533
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0312032

Informations de copyright

Copyright: © 2024 Yamamoto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

TY has received lecturer fees from AstraZeneca KK, Amgen KK, AiRato Inc and Takeda Pharmaceutical Co., Ltd. KJ has received financial support from Elekta KK in the form of a donation. This does not alter our adherence to PLOS ONE policies on sharing data and materials. ST, NT, RU, YS, KK, SO, KT, HH, KS, YK, and NK declare no conflicts of interest relevant to this work.

Auteurs

Takaya Yamamoto (T)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Shohei Tanaka (S)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Noriyoshi Takahashi (N)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Rei Umezawa (R)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yu Suzuki (Y)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Keita Kishida (K)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

So Omata (S)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kazuya Takeda (K)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Hinako Harada (H)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kiyokazu Sato (K)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yoshiyuki Katsuta (Y)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Noriyuki Kadoya (N)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Keiichi Jingu (K)

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH